Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Viyash Scientific has informed that it enclosed Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2025.
The above information is a part of company’s filings submitted to BSE.